The HER2 (human epidermal growth factor receptor 2)/neu gene, one of four members of the epidermal growth factor receptor (EGFR) family, was identified as a contributor to the development of breast cancer in patients through the ground-breaking work of William Muller et al. Here, EGFR is linked to breast carcinoma.